España Fernandez, S.; Sun, C.; Solé-Blanch, C.; Boada, A.; MartÃnez-Cardús, A.; Manzano, J.L.
Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance? Pharmaceutics 2023, 15, 823.
https://doi.org/10.3390/pharmaceutics15030823
AMA Style
España Fernandez S, Sun C, Solé-Blanch C, Boada A, MartÃnez-Cardús A, Manzano JL.
Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance? Pharmaceutics. 2023; 15(3):823.
https://doi.org/10.3390/pharmaceutics15030823
Chicago/Turabian Style
España Fernandez, Sofia, Chen Sun, Carme Solé-Blanch, Aram Boada, Anna MartÃnez-Cardús, and José Luis Manzano.
2023. "Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance?" Pharmaceutics 15, no. 3: 823.
https://doi.org/10.3390/pharmaceutics15030823
APA Style
España Fernandez, S., Sun, C., Solé-Blanch, C., Boada, A., MartÃnez-Cardús, A., & Manzano, J. L.
(2023). Immunotherapy Resumption/Rechallenge in Melanoma Patients after Toxicity: Do We Have Another Chance? Pharmaceutics, 15(3), 823.
https://doi.org/10.3390/pharmaceutics15030823